2,016
Participants
Start Date
August 4, 2020
Primary Completion Date
September 13, 2024
Study Completion Date
September 30, 2024
Patient Registry Data
To set data on demographic characteristics,documenting antithrombotic therapy, describe the INR control level of VKA users, discontinuation rates and clinical outcomes, such as stroke, hemorrhage and death.
"Hospital Interzonal General de Agudos Dr. José Penna", Bahía Blanca
DIM Clínica Privada, Ramos Mejía
Centro de Investigaciones Medicas Temperley (CIMeT), Temperley
Hospital Italiano de La Plata, Buenos Aires
Centro Modelo de Cardiologia, San Miguel de Tucumán
Centro Medico Luquez, Córdoba
Prevención Cardiovascular Salta, Salta
Servicios Médicos El Castaño, San Juan
Instituto Cardiovascular San Luis, San Luis
Centro de Investigaciones Clinicas del Litoral SRL, Santa Fe
Hospital Provincial Dr. José Maria Cullen, Santa Fe
Hospital Alvorada Taguatinga Ltda, São Paulo
Sociedad de Cirugia de Bogota - Hospital de San Jose, Bogotá
Fundacion Valle del Lili, Santiago de Cali
Francisco Gerardo Padilla Padilla, Guadalajara
Centro de Estudios Clínicos de Queretaro S.C. (CECLIQ), Querétaro City
Centro para el Desarrollo de la Medicina y de Asistecia Medica Especializada S.C., Culiacán
Lead Sponsor
Brazilian Clinical Research Institute
OTHER